Comments
Loading...
BiomX (AMEX:PHGE) Stock Quotes, Forecast and News Summary
BiomX Stock (AMEX: PHGE) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy BiomX (PHGE) stock?
You can purchase shares of BiomX (AMEX:PHGE) through any online brokerage.
Who are BiomX (PHGE) competitors?
Other companies in BiomX’s space includes: Eterna Therapeutics (NASDAQ:ERNA), NKGen Biotech (NASDAQ:NKGN), Acurx Pharmaceuticals (NASDAQ:ACXP), Cellectar Biosciences (NASDAQ:CLRB) and Imunon (NASDAQ:IMNN).
What is the forecast, or price target, for BiomX (PHGE) stock?
BiomX has a consensus price target of $3.63.
What is the current price for BiomX (PHGE)?
The stock price for BiomX (AMEX: PHGE) is $0.93 last updated February 21, 2025 at 9:48 AM EST.
Does BiomX (PHGE) pay a dividend?
There are no upcoming dividends for BiomX.
When is BiomX (AMEX:PHGE) reporting earnings?
BiomX’s Q1 earnings are confirmed for Monday, May 19, 2025.
Is BiomX (PHGE) going to split?
There is no upcoming split for BiomX.
What sector and industry does BiomX (PHGE) operate in?
BiomX is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.